The following is a guest blog by Ryan MacDonald, volunteer co-chair of JDRF Canada’s $100M Campaign to Accelerate – JDRF’s bold fundraising campaign to raise $100M by 2025 to accelerate research to defeat the monster known as type 1 diabetes (T1D). Generous donor support is fueling our campaign to help us reach our goal. Ryan […]
50% of profits go to JDRF Warrior Hill was founded by a family with both a parent and child who live with type 1 diabetes (T1D) who have a passion for sports and a commitment to helping people with diabetes perform their best. When Lisa and Aaron Hill’s (who lives with T1D himself) son Luke […]
Content repurposed with permission from: type1better.com Despite best efforts to keep a child’s blood glucose within target, severe hypoglycemic episodes can happen, and it’s best to be prepared for the unpredictable. The risk of severe hypoglycemia is higher in children with T1D than in adults with T1D. This could be due to children being less aware of […]
A significant part of JDRF Canada funding goes towards supporting cure-based research for type 1 diabetes (T1D). One such pathway is via stem cell replacement therapies that replace the beta cells responsible for producing insulin killed in the autoimmune process during T1D. The goal is to implant new beta cells that can one day start […]
Throughout June more than 40 communities gathered across Canada to raise funds for type 1 diabetes research. The Sun Life Walk to Cure Diabetes for JDRF is the largest fundraising event in Canada that brings together the type 1 diabetes (T1D) community to raise funds for T1D research. A fun-filled family and community celebration, the […]
A 2013-2016 JDRF-funded study showed that the use of a continuous glucose monitor (CGM) during pregnancy for people with type 1 diabetes (T1D) results in healthier pregnancies and babies. The CONCEPTT study examined the use of CGMs during pregnancy in over 300 people with T1D. The use of a CGM during and prior to pregnancy […]
The American Diabetes Assocation’s 83rd Scientific Sessions were held from June 23- 26th. This annual conference brings together researchers and scientists to both present and learn about the latest in type 1 diabetes research and technological advancements. Many of the presenters are funded by JDRF International, JDRF Canada’s affiliate in the United States. JDRF-funded researchers […]
What is Glucagon? Glucagon is a hormone that helps the liver release glucose to raise blood glucose levels. It can be administered through injection, auto-injection pen or nasal spray. Glucagon is generally used when a person with type 1 diabetes (T1D) is unable to swallow liquid or food because of severe hypoglycemia (low blood glucose) […]
JDRF Canada, in collaboration with CIHR, is thrilled to announce the recipients of the CIHR-JDRF Type 1 Diabetes Screening Research Consortium. This $12 million grant will develop a single nationally coordinated research network to explore key research questions about the feasibility and acceptability of general population screening for early-stage T1D in Canada. The consortium will […]
The name Garfinkle is synonymous with JDRF Canada. Over 50 years ago, in 1971 and 1973 respectively, Krayna Golfman and Mitch Garfinkle saw their sons, David and Jimmy diagnosed with type 1 diabetes (T1D). They joined forces with other families affected by the disease to begin their lifelong mission of finding cures for T1D while […]
Low blood sugar, called hypoglycemia, is a real fear for people with type 1 diabetes (T1D). Although there are rescue treatments for it, such as injectable or nasal glucagon (Baqsimi), there are currently no preventive therapies available. Canadian company Zucara Therapeutics, however, may have an answer.
On May 23, 2023 the U.S. Food and Drug Administration (FDA) cleared the iLet® Insulin-Only Bionic Pancreas System for people 6 years of age and older with type 1 diabetes (T1D). It is an artificial pancreas system designed to autonomously determine and deliver insulin doses to control blood glucose levels. What is an ‘artificial pancreas’? […]
